As part of Proposition 64 funding to the CMCR, the Center is pleased to announce four new studies that have been selected for funding this year. These proposals were submitted in response to the Spring 2026 call for proposals, which was open to all California higher education and nonprofit research institutions. The final selection was based on external peer review, advice of the CMCR’s National Advisory Council, and attentiveness to CMCR priorities.
Principal Investigator: Michael Taffe, PD, Professor, Department of Psychiatry
Institution: UCSD
Title: Cannabinoid alteration of the reinforcing effects of exercise in rats
Funding amount: $300,000
Dr. Taffe's research will explore how THC may enhance the reinforcing effects of physical exercise and how physical exercise may diminish the rewarding effect of drugs.
Principal Investigator: Nathaniel Schuster, MD, Professor of Anesthesiology
Institution: UCSD
Title: Vaporized cannabis flower for the acute treatment of migraine: a randomized, double-blind, placebo-controlled trial with open-label extension
Funding amount: $825,000
Dr. Schuster's research proposes to evaluate the efficacy of vaporized cannabis for acute migraine in a phase 3 randomized, double-blind, placebo- controlled study.
Congratulations to the new CMCR Investigators!
- Igor Grant, MD, Director